North Dakota State Board of Pharmacy v. Snyder's Drug Stores, Inc.

AMIH Majority Owned Subsidiary, EPIQ Scripts, Obtains Additional 27 U.S. State Board of Pharmacy Licenses Expanding its Online Mail-Order Pharmacy Operations

Retrieved on: 
Tuesday, November 29, 2022
COVID-19, Cyprus Securities and Exchange Commission, EPIQ, Master service agreement, Prescription, Insurance, Exercise, Telehealth, North Dakota State Board of Pharmacy v. Snyder's Drug Stores, Inc., Security (finance), MSA, Pharmacy, Risk, Form, OTCQB, Quality of life

Dallas, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), (“AMIH” or the “Company”), a diversified holding company that develops, acquires, and operates technology-based health and wellness companies, is pleased to announce that its majority owned subsidiary, EPIQ Scripts, LLC (“EPIQ Scripts”), has obtained an additional 27 state board of pharmacy licenses expanding its online mail-order specialty compounding pharmacy operation. Securing and obtaining licenses and accreditations in all 50 states across the U.S. has been one of EPIQ Scripts’ primary initiatives since inception in order to attract diverse telemedicine companies seeking to reach and support customers on a national level.

Key Points: 
  • More information about the MSA can be found in more detail on the Form 8-K filed by AMIH on September 8, 2022.
  • Securing pharmacy licenses in all 50 states across the U.S. has been one of our primary goals over the last several months.
  • Today the AMIH portfolio encompasses telemedicine and other virtual health platforms, subscriber based primary care and concierge medicine plans, and an online digital mail order pharmacy.
  • If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

American International Holdings Corp. Launches EPIQ Scripts Online Mail-Order Pharmacy

Retrieved on: 
Tuesday, February 15, 2022
Online, API, Research, Cyprus Securities and Exchange Commission, Contract, Private Securities Litigation Reform Act, Compliance, Hers, McKinsey & Company, Consumer, SR, Pharmacy, DEA, Knowledge, DNA, COVID-19, North Dakota State Board of Pharmacy v. Snyder's Drug Stores, Inc., LLC, NCPDP, Company, Homs, CVS Pharmacy, GoodRx, Â, Risk, American, NL Dukhov All-Russian Research Institute of Automation, Government, OTCQB, WHK, MD, U.S. Securities and Exchange Commission, Sultan, Maja, GLOBE, CAGR, ASP, Patient, Quality of life, CEO, Forward-looking statement, URAC, Solution, Security (finance), Sykes, NPI, Insurance, Prescription, Venture capital, Physician, Growth, Exercise, EPIQ, Internet, Telehealth, Healthcare, Hospital

Plano, Texas, Feb. 15, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), (“AMIH” or the “Company”) a diversified holding company that develops, acquires and operates technology-based health and wellness companies, is pleased to announce the launch of EPIQ Scripts, LLC (“EPIQ Scripts”), an online mail-order pharmacy with a specific target to service customers and patients through the growing number of telemedicine companies entering into the market. EPIQ Scripts will initially focus its efforts on obtaining licenses and accreditations in key states with plans to ultimately secure licenses and accreditations in all 50 states across the U.S.

Key Points: 
  • EPIQ Scripts will be led by pharmacy and healthcare industry veterans, Sultan Haroon and Maja Matthews, who collectively have over 40 years of experience in healthcare, pharmacy ownership, operations, and management.
  • Mr. Sultan Haroon started his successful pharmacy career with American Specialty Pharmacy.
  • Prior to her venturing out on her own, Maja was District Trainer and Sr. Pharmacy Technician with CVS Pharmacy.
  • About American International Holdings Corp.
    American International Holdings Corp. (OTCQB: AMIH) is an investor, developer and asset manager of diversified, synergistic health and wellness businesses.